ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 4 analysts with an average price target of $20.07. This is a potential upside of $5.41 (36.9%) from yesterday's end of day stock price of $14.66.

Adverum Biotechnologies's activity chart (see below) currently has 46 price targets and 51 ratings on display. The stock rating distribution of ADVM is 55.56% HOLD and 44.44% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.92% with an average time for these price targets to be met of 301.91 days.

Highest price target for ADVM is $6, Lowest price target is $4, average price target is $20.07.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 06-Feb-2024. First documented stock forecast 25-Aug-2014.

Currently out of the existing stock ratings of ADVM, 5 are a HOLD (55.56%), 4 are a BUY (44.44%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$-10.66 (-72.71%)

2

1 months 23 days ago

4/4 (100%)

$1.5 (60.00%)

279

Buy

6

$4.05 (207.69%)

4

6 months 24 days ago

4/7 (57.14%)

$4.22 (237.08%)

196

Buy

4

$-10.66 (-72.71%)

2

7 months 18 days ago

4/4 (100%)

$2.11 (111.64%)

432

Hold

3

$-11.66 (-79.54%)

6

1 years 4 months 18 days ago

3/4 (75%)

$2.23 (289.61%)

528

Hold

2

$-12.66 (-86.36%)

5

2 years 8 months 6 days ago

3/3 (100%)

$-0.36 (-15.25%)

397

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 301.91 days on average for the stock forecasts to be realized with a an average price target met ratio 82.92

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

JAMES LEE

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

James Lee works at MIZUHO and has 38 price targets and 24 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $36.34

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Mani Foroohar with lowest potential downside - -$12.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?